“For the daily diagnostic routine of lung cancers, a basic molecular study is performed in most facilities, compared to what is possible with NGS technology, so more than 50% of non-small cell lung cancers risk not being adequately characterized by a molecular point of view. “Thus Marcello Tiseo, associate professor of Oncology at the University of Parma, commented on the advantages of the new NGS tests during a webinar promoted by The European House Ambrosetti with the non-conditioning contribution of Amgen.
#Molecular #oncology #Tiseo #lung #tumors #characterized